Clinical study on the Prevention of recurrence of choledocholithiasis after ERCP with Lidan Xiaoshi Mixture
- Conditions
- Choledocholithiasis
- Registration Number
- ITMCTR2000003910
- Lead Sponsor
- Dongfang Hospital University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who were diagnosed as primary choledocholithiasis by first-line examination (laboratory examination + B-ultrasound) and / or second-line examination (CT or MRCP) and successfully completed ERCP lithotomy;
2. Patients aged from 18 to 70 years old;
3. Patients who did not take choleretic drugs within one month before operation.
1. Patients without choledocholithiasis or unsuccessful choledocholithotomy;
2. Patients with biliary stricture;
3. Patients with non primary choledocholithiasis such as cholecystolithiasis and hepatolithiasis;
4. Patients with mental illness;
5. Patients with other serious chronic diseases;
6. Pregnant and lactating women.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The recurrence rate;
- Secondary Outcome Measures
Name Time Method Bile biochemistry;